0.2199
0.0231 (11.74%)
0.0231 (11.74%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,370,560 |
|
|||||
| News | - | ||||||
| Day High | 0.239 | Low High |
|||||
| Day Low | 0.2013 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aeterna Zentaris Inc | AEZS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.0231 | 11.74% | 0.2199 | 19:57:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.2013 | 0.2013 | 0.239 | 0.2161 | 0.1968 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,627 | 1,370,560 | $ 0.2164725 | $ 296,689 | - | 0.1645 - 0.975 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:08 | 50 | $ 0.2116 | USD |
Period:
Draw Mode:
Aeterna Zentaris Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 26.70M | 121.40M | 121.28M | $ 5.16M | $ - | - | -3.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Aeterna Zentaris News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEZS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1919 | 0.345 | 0.18 | 0.245632 | 6,050,969 | 0.028 | 14.59% |
| 1 Month | 0.1932 | 0.345 | 0.1645 | 0.2331825 | 2,008,697 | 0.0267 | 13.82% |
| 3 Months | 0.35 | 0.3648 | 0.1645 | 0.2361582 | 1,114,236 | -0.1301 | -37.17% |
| 6 Months | 0.3605 | 0.4395 | 0.1645 | 0.2885043 | 881,658 | -0.1406 | -39.0% |
| 1 Year | 0.8838 | 0.975 | 0.1645 | 0.5262154 | 1,273,031 | -0.6639 | -75.12% |
| 3 Years | 2.99 | 3.62 | 0.1645 | 1.14 | 3,026,832 | -2.77 | -92.65% |
| 5 Years | 1.00 | 5.5869 | 0.1645 | 1.31 | 2,089,102 | -0.7801 | -78.01% |
Aeterna Zentaris Description
| AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. |